These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24610155)

  • 1. Questionnaire-based survey on chemotherapy-induced anemia.
    Tanaka A; Yoshino I; Makino S; Katsumata N; Takahashi K; Kuwano H; Maehara Y; Nishiyama M
    Int J Clin Oncol; 2014; 19(3):411-20. PubMed ID: 24610155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Questionnaire-based survey on chemotherapy-induced anemia].
    Tanaka A
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):421-5. PubMed ID: 24743357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review.
    Henry DH; Langer CJ; McKenzie RS; Piech CT; Senbetta M; Schulman KL; Stepanski EJ
    Support Care Cancer; 2012 Sep; 20(9):2089-96. PubMed ID: 22160485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese physician perception on the treatment of chemotherapy-induced anemia: online cross-section survey study.
    Zhang J; Du Y; Meng Y; Liu X; Mu Y
    Chin Clin Oncol; 2024 Feb; 13(1):5. PubMed ID: 38453656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Darbepoetin Alfa for Chemotherapy-induced Anemia When Initiated at Hemoglobin ≤10 g/dL.
    Pirker R; Hedenus M; Vansteenkiste J; Hernandez E; Belton L; Terwey JH
    Clin Ther; 2016 Jan; 38(1):122-135.e6. PubMed ID: 26730453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study.
    Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S
    Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of cancer chemotherapy-associated anemia in Japan - conditions and issues].
    Yoshino I
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):426-31. PubMed ID: 24743358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in anemia treatment among patients with five non-myeloid malignancies treated with chemotherapy in a large integrated health care delivery system in California, 2000-2013.
    Xu L; Xu H; Cannavale K; Sattayapiwat O; Rodriguez R; Page JH; Chao C
    Support Care Cancer; 2016 Jul; 24(7):2989-98. PubMed ID: 26872791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥ 10 g/dL: an exploratory analysis of a phase 3 trial.
    Canon JL; Vansteenkiste J; Hedenus M; Gascon P; Bokemeyer C; Ludwig H; Vermorken J; Legg J; Pujol B; Bridges K
    Med Oncol; 2012 Sep; 29(3):2291-9. PubMed ID: 22081263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
    Nowrousian MR
    Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of darbepoetin alfa initiated at hemoglobin ≤10 g/dL in patients with stage IV cancer and chemotherapy-induced anemia.
    Boccia RV; Henry DH; Belton L; Bohac C; Ghazal HH
    Cancer Med; 2016 Dec; 5(12):3445-3453. PubMed ID: 27882724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Frequency of blood transfusions for anemia caused by chemotherapy in ovarian cancer patients. Thoughts about the guidelines modified in 2006 for the treatment of anemic cancer patients by the European Organisation for Research and Treatment of Cancer].
    Lehoczky O; Pulay T
    Orv Hetil; 2007 Nov; 148(45):2133-7. PubMed ID: 17984024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion practice patterns in patients with anemia receiving myelosuppressive chemotherapy for nonmyeloid cancer: results from a prospective observational study.
    Granfortuna J; Shoffner K; DePasquale SE; Badre S; Bohac C; De Oliveira Brandao C
    Support Care Cancer; 2018 Jun; 26(6):2031-2038. PubMed ID: 29349622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Chemotherapy-Induced Anemia in Patients with Non-Hodgkin Lymphoma.
    Cannavale K; Xu H; Xu L; Sattayapiwat O; Rodriguez R; Bohac C; Page J; Chao C
    Perm J; 2019; 23():. PubMed ID: 31314738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
    Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
    Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
    Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
    Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe.
    Deger M; Eisterer W; Kutikova L; Salek S
    Support Care Cancer; 2013 Feb; 21(2):485-93. PubMed ID: 22825456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective review of blood transfusions in cancer patients with anemia.
    Estrin JT; Schocket L; Kregenow R; Henry DH
    Oncologist; 1999; 4(4):318-24. PubMed ID: 10476543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.